The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in patients with relapsed/refractory Hodgkin lymphoma (RR-HL) with progression after autologous stem cell transplantation in the current era of novel therapeutics.
 
Steven Michael Bair
No Relationships to Disclose
 
Lauren E. Strelec
Research Funding - Celgene (Inst); MedImmune (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - MedImmune
 
Sunita Nasta
Research Funding - Millennium
 
Anthony R. Mato
No Relationships to Disclose
 
Daniel Jeffrey Landsburg
No Relationships to Disclose
 
Edward Allen Stadtmauer
Consulting or Advisory Role - Celgene; Novartis
 
Alison W. Loren
Research Funding - Merck
 
Stephen J. Schuster
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Novartis; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Jakub Svoboda
Consulting or Advisory Role - Seagen
Research Funding - Celgene; MedImmune; Pharmacyclics; Seagen